Both in Biotechnology
Atara Biotherapeutics vs Cognition Therapeutics
Over the past year ATRA returned −43.1% and CGTX returned −52.9%; their daily moves had a correlation of 0.07.
ATRA −43.1% CGTX −52.9%Growth of $1, one year, split-adjusted
| Metric | ATRA | CGTX |
|---|---|---|
| Price | $8.66 | $0.7490 |
| Market cap | $86.9M | $71.2M |
| Today | +4.34% | −1.33% |
| 1 month | +7.6% | −21.5% |
| 6 months | +88.3% | −36.5% |
| Year to date | −52.1% | −44.5% |
| 1 year | −44.5% | −55.4% |
| Revenue growth (YoY) | −96.4% | — |
| Gross margin | 69.7% | — |
| Net margin | −767.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.0× | — |
| Net cash | $9.9M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 51.9% |
| Short % of float | 11.2% | 8.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).